Prognosis

China’s Role as Global Drug Hub Raises Alarms in Washington

Eshoo plans House hearing as Pentagon sees national-security risks in pharmaceutical supply chain

Photographer: Qilai Shen/Bloomberg
Lock
This article is for subscribers only.

A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.

Democratic Representative Anna Eshoo is warning fellow lawmakers that if the trade war between Washington and Beijing were to intensify, China could throw the U.S. into chaos by cutting off the vast supply of important drug components made in the Asian nation.